monoclonal antibodies articles & resources on Made-in-China.com

GE Healthcare, Sealed Air Expand Alliance to Develop Films for Bioprocessing Applications

Aug 24, 2016

GE Healthcare’s Life Sciences business has entered into an agreement with Sealed Air to further develop new films for bioprocessing applications. The companies will develop novel films for single-use bioprocess systems, as part of ...

Tags: GE Healthcare, Sealed Air, Life Sciences

Creative Biolabs Has Always Been Highly Recommended Through The Whole Industry

Dec 2, 2014

Humanization is significant for reducing the immunogenicity of monoclonal antibodies derived from rodent sources and for improving their activation of the human immune system. Rodent antibodies are highly immunogenic in humans, which ...

Tags: monoclonal antibodies, immune system, Health

Covagen Announced It Has Secured CHF42m in a Tranched Series B Financing

Dec 11, 2013

Covagen has announced that the company has secured CHF42m in a tranched Series B financing with an option to obtain an additional CHF14m that would increase the total amount of the financing round to CHF56m. This financing will mainly ...

Tags: Covagen, Medicine

Separation Media Is Launched by Tosoh

Nov 27, 2013

Newly developed Toyopearl AF-r Protein A HC-650F introduced by Tokyo company. Tosoh has launched its newly developed separation media Toyopearl AF-r Protein A HC-650F. The biopharmaceutical industry is growing rapidly in many developed, ...

Tags: Separation Media, Tosoh, Toyopearl

The FDA Has Approved Nexavar for The Treatment of Locally Recurrent or Metastatic

Nov 26, 2013

Germany-based Bayer HealthCare and US-based Onyx Pharmaceuticals have announced that the US Food and Drug Administration (FDA) has approved Nexavar (sorafenib), an oral multi-kinase inhibitor, for the treatment of patients with ...

Tags: Health, Medicine

IBM Research and IBN Discover Deliver Treatment More Efficiently to Fight Breast Cancer

Nov 5, 2013

Scientists from IBM and Singapore’s Institute of Bioengineering and Nanotechnology (IBN) published a breakthrough drug-delivery technique, demonstrating the first biodegradable, biocompatible and non-toxic hydrogel that can deliver ...

Tags: Cancer Drug, Medicine

KARO Has Achieved Its First Milestone in a Research Agreement with Pfizer

Sep 9, 2013

Swedish biotechnology firm Karo Bio (KARO) has achieved its first milestone in a research agreement with Pfizer for the development of drugs for treatment of autoimmune diseases. The achievement of milestone in the RORgamma project ...

Tags: Karo Bio, RORgamma

KU Leuven and FIT Biotech Reached a Global License and Partnership Agreement

Aug 2, 2013

KU Leuven and FIT Biotech have reached a global license and partnership agreement for the development of novel immunotherapeutics leveraging FIT Biotech's gene transport unit (GTU) technology for transient in vivo expression of monoclonal ...

Tags: KU Leuven, Novel Immunotherapeutics

Compugen Is Developing a PSB Infrastructure Platform

Jul 19, 2013

Israeli Drug discovery company Compugen is developing a Predictive Structural Biology (PSB) infrastructure platform to identify the functional interaction sites of proteins, which are useful in the rational design of novel drugs. Intended ...

Tags: Drug discovery, Biology Infrastructure Platform

Lpath Has Won a US patent

May 31, 2013

Lpath has won a US patent covering methods of using monoclonal antibodies for the treatment and prevention of ocular conditions, including wet age-related macular degeneration (AMD). The patent includes the use of monoclonal antibodies, ...

Tags: Lpath, US Patent

Beckman Coulter Life Sciences Is Expanding Flow Cytometry Portfolio with 14 New Antibodies

Feb 1, 2013

Beckman Coulter Life Sciences is expanding their flow cytometry portfolio with the addition of 14 new human monoclonal antibodies from Trillium Diagnostics LLC. The analyte specific reagents (ASRs) provide high specificity, convenience and ...

Tags: Cytometry Portfolio, flow cytometry, Antibodies

AIMM Therapeutics Collaborated to Develop Oral Diagnostic and Therapeutic Antibodies

Dec 27, 2012

Therapeutic antibody company AIMM Therapeutics has collaborated with Italy-based Cosmo Pharmaceuticals to develop oral diagnostic and therapeutic antibodies for gastrointestinal diseases, including colon carcinoma. As part of the ...

Tags: AIMM, Cosmo Pharmaceuticals, gastrointestinal therapy

Genentech Received US FDA Approval of Priority Review Designation for Trastuzumab BLA

Dec 7, 2012

Roche Group member, Genentech has received US Food and Drug Administration (FDA) official approval of priority review designation for trastuzumab emtansine Biologics License Application (BLA). Trastuzumab Emtansine is designed to treat ...

Tags: HER2-positive metastatic breast cancer, Roche Group

CST Has Developed Monoclonal Antibody Discovery Platform, NG-XMT

Nov 29, 2012

Cell Signaling Technology (CST) has developed monoclonal antibody discovery platform, NG-XMT, for antigen-specific monoclonal antibodies. The antibody discovery technology combines the power of proteomics to identify and clone ...

Tags: NG-XMT, clone, monoclonal antibodies

Medistem and Superview Biotechnology Collaborate for Development of Stem Cell Technology.

Nov 29, 2012

Medistem and Superview Biotechnology, a subsidiary of Yinhuan Holding Co from Yixing, collaborate for the development of therapeutics using antibody and stem cell technology. The collaboration will leverage proprietary stem cell lines ...

Tags: therapeutics, antibody and stem cell technology, regenerative medicine

monoclonal antibodies

Related Products